HC Wainwright & Co. Maintains Buy on Innoviva, Raises Price Target to $46

Benzinga · 1d ago
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $45 to $46.